Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
In the last 90 days, Oramed Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Oramed Pharmaceuticals Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $942.2K in total
- Insiders trading
- 2
- Net value
- −$942.2K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Oramed Pharmaceuticals Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kidron Nadav | President and CEO | 4,140,505 | Sep 25, 2026 | 6 |
| Hexter Joshua | COO & CBO | 1,358,130 | Sep 25, 2026 | 5 |
| Kidron Miriam | Chief Scientific Officer | 1,550,554 | Sep 25, 2026 | 6 |
| Gabay Avraham | Chief Financial Officer | 881,076 | Sep 25, 2026 | 5 |
| Mayer Arie | Director | 168,009 | Jan 5, 2026 | 1 |
| Shapiro Benjamin | Director | 123,220 | Jan 5, 2026 | 1 |
| Reznick Yehuda | Director | 105,180 | Jan 5, 2026 | 1 |
| Aghion Daniel | Director | 113,441 | Jan 2, 2026 | 1 |
| Sank Leonard | Director | 134,531 | Jun 9, 2025 | 0 |
| Silberman David | Chief Financial Officer | 366,500 | Jan 8, 2024 | 0 |
| Rozov Yadin | Director | 155,320 | Jan 8, 2024 | 0 |
| Derovan Netanel | Chief Legal Officer | 149,500 | May 31, 2023 | 0 |
| Rabinowitz Michael | Chief Commercial Officer | 126,143 | Jan 4, 2023 | 0 |
| Rakin Kevin | Director | 46,661 | Mar 22, 2022 | 0 |
| Friedman Aviad | Director | 0 | Jan 5, 2022 | 0 |
| Rabinowitz Michael | Chief Commercial Officer | 109,468 | Jan 5, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 (view filing)5:00 PM ET | Jul 1 | 1 day | Hexter JoshuaCOO & CBO | SSale | −137.0K | $4.46 | −$611.4K | −11.8%1.02M after | |
| Jul 2, 2026 (view filing)5:00 PM ET | Jul 1 | 1 day | Gabay AvrahamChief Financial Officer | SSale | −73.4K | $4.51 | −$330.7K | −9.8%671.8K after | |
| Apr 4, 2023 (view filing) | Apr 3-4 | 1 day | Mayer ArieDirector | PPurchase | +8.81K | $2.22 | +$19.5K | +48.9%26.8K after | 2 lots |
| Mar 16, 2023 (view filing) | Mar 16 | Same day | Kidron NadavPresident and CEO | PPurchase | +26.0K | $2.04 | +$53.0K | +26.0%126.0K after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Kidron NadavPresident and CEO | PPurchase | +100.0K | $2.01 | +$201.0K | New position100.0K after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Kidron MiriamChief Scientific Officer | SSale | −100.0K | $2.01 | −$201.0K | −33.1%201.7K after | |
| Mar 15, 2023 (view filing) | Mar 13-14 | 2 days | Rozov YadinDirector | PPurchase | +70.0K | $2.02 | +$141.7K | +424.2%86.5K after | 2 lots |
| Jan 4, 2023 (view filing) | Jan 3 | 1 day | Rabinowitz MichaelChief Commercial Officer | SSale | −13.3K | $12.55 | −$167.2K | −9.6%126.1K after | 2 lots |
| May 10, 2022 (view filing) | Nov 1, 2021 | 190 daysLate | Mayer ArieDirector | SSale | −3.00K | $25.60 | −$76.8K | −100.0%0 after | |
| Mar 22, 2022 (view filing) | Mar 21 | 1 day | Rakin KevinDirector | SSale | −10.0K | $9.41 | −$94.1K | −17.6%46.7K after | |
| Dec 7, 2021 (view filing) | Aug 9 | 120 days | Kidron NadavPresident and CEO | SSale | −220.0K | $20.11 | −$4.42M | −23.0%738.2K after | Amended |
| Sep 20, 2021 (view filing) | Sep 16 | 4 days | Rakin KevinDirector | SSale | −21.1K | $20.99 | −$442.9K | −27.0%57.0K after |